Press releases
- AngioDynamics’ APEX-AV Trial Results Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism Presented at SCAI 2024 Scientific Sessions
- AngioDynamics Reports Fiscal Year 2024 Third Quarter Financial Results; Updates Fiscal Year 2024 Guidance to Reflect Asset Divestiture
- AngioDynamics Receives 510(k) Clearance for AlphaVac F18⁸⁵ System in Treatment of PE
- AngioDynamics Announces Settlement of All Patent Litigation with C.R. Bard, Inc.
- AngioDynamics to Report Fiscal 2024 Third Quarter Financial Results on April 4, 2024
- AngioDynamics to Participate in a Fireside Chat at the Oppenheimer Virtual Healthcare MedTech & Services Conference
- AngioDynamics Announces Sale of PICC and Midline Product Portfolios to Spectrum Vascular for $45 Million
More ▼
Key statistics
On Tuesday, AngioDynamics Inc (ANGO:DEU) closed at 5.65, 18.70% above the 52 week low of 4.76 set on Mar 26, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 5.65 |
---|---|
High | 5.70 |
Low | 5.60 |
Bid | 5.60 |
Offer | 5.80 |
Previous close | 5.65 |
Average volume | 25.00 |
---|---|
Shares outstanding | 40.05m |
Free float | 38.05m |
P/E (TTM) | -- |
Market cap | 245.93m USD |
EPS (TTM) | -4.78 USD |
Data delayed at least 15 minutes, as of May 07 2024.
More ▼